Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessmentJason R. Clapper, Jonathan D. Roth, Joseph S. Heilig et al.|American Journal of Physiology-Gastrointestinal and Liver Physiology|2013Cited by 294
Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weightChristine M. Mack, David G. Parkes, Bronislava Gedulin et al.|International Journal of Obesity|2009Cited by 112
Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weightChristine M. Mack, David G. Parkes, Julie Wilson et al.|American Journal of Physiology-Regulatory, Integrative and Comparative Physiology|2007Cited by 109
Combination Therapy with Amylin and Peptide YY[3–36] in Obese Rodents: Anorexigenic Synergy and Weight Loss AdditivityJonathan D. Roth, David G. Parkes, Todd Coffey et al.|Endocrinology|2007Cited by 77
Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet‐induced obese and leptin‐deficient rodentsJames L. Trevaskis, Jonathan D. Roth, Changqi Sun et al.|Diabetes Obesity and Metabolism|2014Cited by 59